Authors:
Eksandh, L
Ekstrom, U
Abrahamson, M
Bauer, B
Andreasson, S
Citation: L. Eksandh et al., Different clinical expressions in two families with Stargardt's macular dystrophy (STGD1), ACT OPHTH S, 79(5), 2001, pp. 524-530
Authors:
Janowski, R
Kozak, M
Jankowska, E
Grzonka, Z
Grubb, A
Abrahamson, M
Jaskolski, M
Citation: R. Janowski et al., Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping, NAT ST BIOL, 8(4), 2001, pp. 316-320
Authors:
Kasprzykowski, F
Kasprzykowska, R
Kania, P
Plucinska, K
Grubb, A
Abrahamson, M
Schalen, C
Citation: F. Kasprzykowski et al., Peptidyl diazomethylketones as cysteine protease inhibitors structurally based upon the inhibitory centers of cystatins, POL J CHEM, 75(6), 2001, pp. 831-837
Authors:
Monteiro, ACS
Abrahamson, M
Lima, APCA
Vannier-Santos, MA
Scharfstein, J
Citation: Acs. Monteiro et al., Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi, J CELL SCI, 114(21), 2001, pp. 3933-3942
Authors:
Stoka, V
Turk, B
Schendel, SL
Kim, TH
Cirman, T
Snipas, SJ
Ellerby, LM
Bredesen, D
Freeze, H
Abrahamson, M
Bromme, D
Krajewski, S
Reed, JC
Yin, XM
Turk, V
Salvesen, GS
Citation: V. Stoka et al., Lysosomal protease pathways to apoptosis - Cleavage of Bid, not pro-caspases, is the most likely route, J BIOL CHEM, 276(5), 2001, pp. 3149-3157
Authors:
Johansson, L
Grubb, A
Abrahamson, M
Kasprzykowski, F
Kasprzykowska, R
Grzonka, Z
Lerner, UH
Citation: L. Johansson et al., A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro, BONE, 26(5), 2000, pp. 451-459
Authors:
John, RJ
Rusznak, C
Ramjee, M
Lamont, AG
Abrahamson, M
Hewitt, EL
Citation: Rj. John et al., Functional effects of the inhibition of the cysteine protease activity of the major house dust mite allergen Der p 1 by a novel peptide-based inhibitor, CLIN EXP AL, 30(6), 2000, pp. 784-793
Authors:
Pavlova, A
Krupa, JC
Mort, JS
Abrahamson, M
Bjork, I
Citation: A. Pavlova et al., Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutationof His110, FEBS LETTER, 487(2), 2000, pp. 156-160
Authors:
Huh, CG
Hakansson, K
Nathanson, CM
Thorgeirsson, UP
Jonsson, N
Grubb, A
Abrahamson, M
Karlsson, S
Citation: Cg. Huh et al., Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene, J CL PATH-M, 52(6), 1999, pp. 332-340
Authors:
Kozak, M
Jankowska, E
Janowski, R
Grzonka, Z
Grubb, A
Fernandez, MA
Abrahamson, M
Jaskolski, M
Citation: M. Kozak et al., Expression of a selenomethionyl derivative and preliminary crystallographic studies of human cystatin C, ACT CRYST D, 55, 1999, pp. 1939-1942
Authors:
Alvarez-Fernandez, M
Barrett, AJ
Gerhartz, B
Dando, PM
Ni, JA
Abrahamson, M
Citation: M. Alvarez-fernandez et al., Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site, J BIOL CHEM, 274(27), 1999, pp. 19195-19203
Authors:
Coulibaly, S
Schwihla, H
Abrahamson, M
Albini, A
Cerni, C
Clark, JL
Ng, KM
Katunuma, N
Schlappack, O
Glossl, J
Mach, L
Citation: S. Coulibaly et al., Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C, INT J CANC, 83(4), 1999, pp. 526-531
Authors:
Ekstrom, U
Abrahamson, M
Floren, CH
Tollig, H
Wettrell, G
Nilsson, E
Sun, XM
Soutar, AK
Nilsson-Ehle, P
Citation: U. Ekstrom et al., An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F), CLIN GENET, 55(5), 1999, pp. 332-339
Authors:
Bjarnadottir, M
Wulff, BS
Sameni, M
Sloane, BF
Keppler, D
Grubb, A
Abrahamson, M
Citation: M. Bjarnadottir et al., Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells, J CL PATH-M, 51(6), 1998, pp. 317-326
Citation: B. Gerhartz et al., Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C, BIOCHEM, 37(49), 1998, pp. 17309-17317